This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Paolo Lembo: Innovator in Pharmaceutical Screening
Introduction
Paolo Lembo is a notable inventor based in St. Laurent, CA, recognized for his valuable contributions to the field of pharmaceutical research. He has developed innovative methodologies that assist in drug discovery, significantly impacting the industry. With a single patent to his name, Lembo focuses on specific receptor interactions that have implications for various therapeutic applications.
Latest Patents
Lembo's patent is titled "Assays to screen for compounds that bind the dorsal root receptor." This innovative work is directed towards assays designed to screen for compounds that act as agonists, antagonists, or inverse agonists of bovine adrenal medulla docosapeptide (BAM-22P). The assays leverage the binding efficacy of BAM-22P to both rat and human dorsal root receptor (DRR) receptors, showcasing a critical advancement in understanding receptor dynamics and drug interaction potential.
Career Highlights
Paolo Lembo is employed at AstraZeneca AB, a prominent global biopharmaceutical company that emphasizes the importance of innovative research in developing life-changing medications. His role at AstraZeneca AB allows him to collaborate with leading experts in the field and contribute to the company's extensive portfolio of drugs.
Collaborations
Throughout his career, Lembo has worked alongside skilled professionals such as Sultan Ahmad and Eric Grazzini. These collaborations enhance the research environment, combining their expertise to innovate and optimize the drug discovery process.
Conclusion
Paolo Lembo's inventive spirit and dedication to pharmaceutical advancements underscore his role as an impactful inventor in the industry. His ability to develop assays for drug screening not only demonstrates his ingenuity but also promises to aid in the discovery of new therapeutic agents. With ongoing collaboration and research, Lembo continues to contribute significantly to the scientific community and the future of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile